Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

What You Need to Know Ahead of Amgen's Earnings Release

Based in Thousand Oaks, California, Amgen Inc. (AMGN) is a global leader in biotechnology, pioneering advancements in human therapeutics. With a market cap of $178.71 billion, Amgen is renowned for its innovative portfolio that enhances patient care through cutting-edge biologics and biosimilars. The company is set to announce its fiscal Q2 earnings results after the market closes on Tuesday, Aug. 6.

Ahead of the event, analysts expect AMGN to report a profit of $4.87 per share, down 2.6% from $5 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.